{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:00:13Z","timestamp":1789754413700,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Department of Health's Experimental Cancer Medicine Centre Award"},{"name":"National Institute for Health Research Biomedical Research Centre"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RP-2016-07-028"],"award-info":[{"award-number":["RP-2016-07-028"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejca.2018.08.019","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T14:14:47Z","timestamp":1539180887000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-4237","authenticated-orcid":false,"given":"Alvaro H.","family":"Ingles Garces","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Ern","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-6781","authenticated-orcid":false,"given":"Malaka","family":"Ameratunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Ch\u00e9nard-Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Diamantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyanarayana","family":"Seeramreddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-1368","authenticated-orcid":false,"given":"Raghav","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"de Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1503-3123","authenticated-orcid":false,"given":"Udai","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2018.08.019_bib1","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/annonc\/mdw218","article-title":"How to report toxicity associated with targeted therapies?","volume":"27","author":"Cabarrou","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2018.08.019_bib2","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/annonc\/mds030","article-title":"Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience","volume":"23","author":"Molife","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2018.08.019_bib3","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.18632\/oncotarget.23536","article-title":"An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)","volume":"9","author":"Ezoe","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2018.08.019_bib4","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2147\/TCRM.S83681","article-title":"Hypercalcemia of malignancy and new treatment options","volume":"11","author":"Glezerman","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ejca.2018.08.019_bib5","first-page":"0","article-title":"Common Terminology criteria for adverse events (CTCAE)","volume":"2009","author":"National Institute of Cancer","year":"2010","journal-title":"NIH Publ"},{"key":"10.1016\/j.ejca.2018.08.019_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3322\/caac.21184","article-title":"Understanding, recognizing, and managing toxicities of targeted anticancer therapies","volume":"63","author":"Dy","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2018.08.019_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/CAD.0b013e32833760bf","article-title":"Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinoma","volume":"21","author":"Rodriguez-Pascual","year":"2010","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.ejca.2018.08.019_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(07)70108-0","article-title":"Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study","volume":"8","author":"Tejpar","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.08.019_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1574886308666140109112730","article-title":"Diuretic-associated electrolyte disorders in the elderly: risk factors, impact, management and prevention","volume":"9","author":"Khow","year":"2014","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.ejca.2018.08.019_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/annonc\/mdj105","article-title":"Management of the adverse effects associated with intravenous bisphosphonates","volume":"17","author":"Tanvetyanon","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2018.08.019_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.ajkd.2013.09.017","article-title":"Dysnatremias in patients with kidney disease","volume":"63","author":"Combs","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejca.2018.08.019_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.rmed.2012.02.010","article-title":"Hyponatremia as prognostic factor in small cell lung cancer \u2013 a retrospective single institution analysis","volume":"106","author":"Hermes","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.ejca.2018.08.019_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/erc.1.00543","article-title":"Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone","volume":"12","author":"Clines","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejca.2018.08.019_bib14","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00345-016-1793-7","article-title":"Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy","volume":"34","author":"Moreira","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.ejca.2018.08.019_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lungcan.2014.07.022","article-title":"Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan","volume":"86","author":"Tiseo","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2018.08.019_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2016.03.007","article-title":"The economic burden of hyponatremia: systematic review and meta-analysis","volume":"129","author":"Corona","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.ejca.2018.08.019_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-7547-4-10","article-title":"Cost of illness of hyponatremia in the United States","volume":"4","author":"Boscoe","year":"2006","journal-title":"Cost Eff Resour Allocation"},{"key":"10.1016\/j.ejca.2018.08.019_bib18","first-page":"4681","article-title":"Clinical characteristics and prognosis of elderly small cell lung cancer patients complicated with hyponatremia: a retrospective analysis","volume":"37","author":"Yang","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2018.08.019_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-016-2610-9","article-title":"The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients","volume":"16","author":"Castillo","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2018.08.019_bib20","first-page":"4104","article-title":"The productions of atrial natriuretic peptide and arginine vasopressin in small cell lung cancer with brain metastases and their associations with hyponatremia","volume":"21","author":"Sun","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ejca.2018.08.019_bib21","doi-asserted-by":"crossref","unstructured":"Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. n.d. doi:10.1530\/EC-18-0109.","DOI":"10.1530\/EC-18-0109"},{"key":"10.1016\/j.ejca.2018.08.019_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0272-6386(12)80667-6","article-title":"Magnesium deficiency: pathophysiologic and clinical overview","volume":"24","author":"al-Ghamdi","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejca.2018.08.019_bib23","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.2008.19.5081","article-title":"Prospective validation of a prognostic score to improve patient selection for oncology phase I trials","volume":"27","author":"Arkenau","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491831339X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491831339X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T13:41:22Z","timestamp":1565271682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491831339X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":23,"alternative-id":["S095980491831339X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.08.019","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}